Xiao‐Feng Zhu

6.7k total citations · 3 hit papers
145 papers, 5.1k citations indexed

About

Xiao‐Feng Zhu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiao‐Feng Zhu has authored 145 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Molecular Biology, 37 papers in Oncology and 32 papers in Cancer Research. Recurrent topics in Xiao‐Feng Zhu's work include RNA modifications and cancer (15 papers), Cancer-related molecular mechanisms research (13 papers) and Autophagy in Disease and Therapy (12 papers). Xiao‐Feng Zhu is often cited by papers focused on RNA modifications and cancer (15 papers), Cancer-related molecular mechanisms research (13 papers) and Autophagy in Disease and Therapy (12 papers). Xiao‐Feng Zhu collaborates with scholars based in China, United States and Hong Kong. Xiao‐Feng Zhu's co-authors include Rong Deng, Gong-Kan Feng, Yi-Xin Zeng, Dandan Li, Irene A. Uchida, Rita B. Effros, Homayoun Vaziri, Daniel Cohen, François Schächter and Lixin Wei and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Xiao‐Feng Zhu

142 papers receiving 5.1k citations

Hit Papers

3 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes.

1993 623 citations Xiao‐Feng Zhu et al. profile →
LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer

2019 374 citations Yun Wang, Jia-Huan Lu et al. Molecular Cancer profile →
Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides

2023 116 citations Xiao‐Feng Zhu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiao‐Feng Zhu China	36	3.0k	1.2k	1.1k	1.0k	632	145	5.1k
Tian Lan China	38	2.3k 0.8×	892 0.7×	920 0.8×	587 0.6×	333 0.5×	134	4.5k
Xin Teng United States	19	3.7k 1.2×	1.4k 1.2×	1.4k 1.3×	540 0.5×	511 0.8×	34	5.3k
Dipali Sharma United States	40	2.8k 0.9×	1.1k 1.0×	1.1k 1.0×	1.4k 1.3×	561 0.9×	100	5.1k
Yaoqin Gong China	40	3.5k 1.1×	951 0.8×	373 0.3×	781 0.8×	379 0.6×	146	5.2k
Alexandru Almasan United States	45	4.4k 1.4×	1.0k 0.8×	671 0.6×	1.9k 1.8×	422 0.7×	96	6.5k
Karin Müller‐Decker Germany	38	2.0k 0.7×	831 0.7×	661 0.6×	654 0.6×	660 1.0×	87	4.6k
Shuichi Kaneko Japan	42	3.2k 1.0×	1.1k 1.0×	2.3k 2.1×	885 0.9×	1.0k 1.6×	191	7.1k
Kwang‐Huei Lin Taiwan	46	3.4k 1.1×	1.8k 1.5×	910 0.8×	923 0.9×	210 0.3×	188	6.2k
Guobin He United States	15	1.7k 0.6×	1.1k 0.9×	1.1k 1.0×	1.1k 1.1×	264 0.4×	25	4.0k
Matilde E. Lleonart Spain	38	3.7k 1.2×	1.8k 1.5×	428 0.4×	1.3k 1.3×	487 0.8×	86	5.6k

Countries citing papers authored by Xiao‐Feng Zhu

Since Specialization

Citations

This map shows the geographic impact of Xiao‐Feng Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Feng Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Feng Zhu more than expected).

Fields of papers citing papers by Xiao‐Feng Zhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao‐Feng Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Feng Zhu. The network helps show where Xiao‐Feng Zhu may publish in the future.

Co-authorship network of co-authors of Xiao‐Feng Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao‐Feng Zhu. A scholar is included among the top collaborators of Xiao‐Feng Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao‐Feng Zhu. Xiao‐Feng Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xiaodong, Xiaohui Yang, Yinmin Gu, et al.. (2025). Tumor-derived extracellular vesicle PD-1 promotes tumor immune evasion via disruption of peripheral T cell homeostasis. Cancer Letters. 612. 217486–217486. 4 indexed citations

Liu, Zebo, Ali Mohsin, Nan Liu, et al.. (2024). A novel perspective on the role of long non-coding RNAs in regulating polyphenols biosynthesis in methyl jasmonate-treated Siraitia grosvenorii suspension cells. Industrial Crops and Products. 213. 118419–118419.

Zhu, Xiao‐Feng, et al.. (2024). Whole Genome Sequencing of a Non-O1/O139-Group Vibrio cholerae Isolated from a Patient with a Bloodstream Infection. Infection and Drug Resistance. Volume 17. 5629–5637. 1 indexed citations

Liu, Shan, Lichao Li, Zhipeng Ye, et al.. (2024). Susceptibility of Mitophagy‐Deficient Tumors to Ferroptosis Induction by Relieving the Suppression of Lipid Peroxidation. Advanced Science. 12(6). e2412593–e2412593. 11 indexed citations

Zhu, Xiao‐Feng, Mohsin Ali, Jianfei Guo, et al.. (2024). A machine learning‐based approach for improving plasmid DNA production in Escherichia coli fed‐batch fermentations. Biotechnology Journal. 19(6). e2400140–e2400140. 2 indexed citations

Liu, Zebo, Nan Liu, Ali Mohsin, et al.. (2023). Insights into chlorogenic acids' efficient biosynthesis through Carthamus tinctorius cell suspension cultures and their potential mechanism as α-glucosidase inhibitors. Industrial Crops and Products. 194. 116337–116337. 10 indexed citations

Wen, Xizhi, Jingjing Li, Hang Jiang, et al.. (2022). HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma. Frontiers in Immunology. 13. 902167–902167. 13 indexed citations

Wei, Wei, Xiaohua Ban, Fan Yang, et al.. (2022). Phase II trial of efficacy, safety and biomarker analysis of sintilimab plus anlotinib for patients with recurrent or advanced endometrial cancer. Journal for ImmunoTherapy of Cancer. 10(5). e004338–e004338. 26 indexed citations

Wu, Rui-Yan, Pengfei Kong, Liang-Ping Xia, et al.. (2019). Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma. Clinical Cancer Research. 25(14). 4530–4541. 80 indexed citations

10.

Wu, Xiaojing, Xiao‐Feng Zhu, Yuanyuan Wang, et al.. (2019). Evaluation of suitable reference genes for gene expression analysis in the northern root-knot nematode, Meloidogyne hapla. PLoS ONE. 14(6). e0218610–e0218610. 3 indexed citations

11.

Wang, Yun, Jia-Huan Lu, Qi-Nian Wu, et al.. (2019). LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer. Molecular Cancer. 18(1). 174–174. 374 indexed citations breakdown →

12.

Yang, Qi, Meng-Xia Zhang, Xiong Zou, et al.. (2017). A Prognostic Bio-Model Based on SQSTM1 and N-Stage Identifies Nasopharyngeal Carcinoma Patients at High Risk of Metastasis for Additional Induction Chemotherapy. Clinical Cancer Research. 24(3). 648–658. 26 indexed citations

13.

Qin, Juan, Jun Tang, Lin Jiao, et al.. (2013). A diterpenoid compound, excisanin A, inhibits the invasive behavior of breast cancer cells by modulating the integrin β1/FAK/PI3K/AKT/β-catenin signaling. Life Sciences. 93(18-19). 655–663. 34 indexed citations

14.

Tang, Jun, et al.. (2012). Houttuyninum, an active constituent of Chinese herbal medicine, inhibits phosphorylation of HER2/neu receptor tyrosine kinase and the tumor growth of HER2/neu-overexpressing cancer cells. Life Sciences. 90(19-20). 770–775. 22 indexed citations

15.

Qin, Wei, et al.. (2011). p38a MAPK is involved in BMP‐2‐induced odontoblastic differentiation of human dental pulp cells. International Endodontic Journal. 45(3). 224–233. 28 indexed citations

16.

Wang, Yao, Rui-Qing Peng, Dandan Li, et al.. (2011). Chloroquine enhances the cytotoxicity of topotecan by inhibiting autophagy in lung cancer cells. Chinese Journal of Cancer. 30(10). 690–700. 54 indexed citations

17.

Hu, Zhe-Yu, Jing Wang, Gang Cheng, et al.. (2011). Apogossypolone targets mitochondria and light enhances its anticancer activity by stimulating generation of singlet oxygen and reactive oxygen species. Chinese Journal of Cancer. 30(1). 41–53. 12 indexed citations

18.

Wu, Xiao-Qi, et al.. (2009). ON-III inhibits erbB-2 tyrosine kinase receptor signal pathway and triggers apoptosis through induction of Bim in breast cancer cells. Cancer Biology & Therapy. 8(8). 739–743. 19 indexed citations

19.

Guan, Zhong, Xiao‐Feng Zhu, Jie Xu, et al.. (2007). Aurora-A, a Negative Prognostic Marker, Increases Migration and Decreases Radiosensitivity in Cancer Cells. Cancer Research. 67(21). 10436–10444. 99 indexed citations

20.

Zhu, Xiao‐Feng, et al.. (2005). SUCI02 inhibits the erbB‐2 tyrosine kinase receptor signaling pathway and arrests the cell cycle in G₁ phase in breast cancer cells. Cancer Science. 97(1). 84–89. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact